Results 261 to 270 of about 58,702 (314)
Usefulness of the combined IFN-γ and IL-2 release test in distinguishing between pulmonary tuberculosis and non-pulmonary tuberculosis. [PDF]
BMC Infect DisWang W, Xu J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Patch testing versus interferon‐gamma release assay in evaluation of drug eruptions
Fundamental & Clinical Pharmacology, 2021Abstract Delayed‐onset T‐cell‐mediated cutaneous adverse drug reactions are an uncommon but potentially serious result of medication exposures. Identification of culprit medications is crucial, but clinical diagnosis is often difficult.
Yehonatan Kaplan +3 more
openaire +3 more sources
Acta Clinica Belgica, 2014
Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly important due to the increasing use of immunosuppressive medications and the human immunodeficiency epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection.
F De Baets
exaly +3 more sources
Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly important due to the increasing use of immunosuppressive medications and the human immunodeficiency epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection.
F De Baets
exaly +3 more sources
Use of Interferon Gamma Release Assays in Children <2 Years Old.
Journal of the Pediatric Infectious Diseases Society, 2023While interferon gamma release assays (IGRA) are widely used for detecting tuberculosis infection, tuberculin skin tests (TST) remain preferred for children under the age of 2 years.
N. Turner +4 more
semanticscholar +1 more source
Tuberculin skin test versus interferon-gamma release assays
Acta Clinica Belgica, 2014Dear Editor,We would like to discuss on the publication on ‘Tuberculin skin test versus interferon-gamma release assays.’1 De Keyser et al.
S S, Tin, V, Wiwanitkit
openaire +2 more sources
High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing
European Journal of Clinical Microbiology & Infectious Diseases, 2020Longitudinal studies regarding the reproducibility of Interferon-gamma release assay (IGRA) T-SPOT.TB for the diagnosis of Mycobacterium tuberculosis (M. tb) infection in serial testing are limited. We retrospectively analysed results of serially tested subjects in a medical laboratory in Germany over a time period of 14 years.
Thomas Meier, Martin Enders
openaire +2 more sources